Davis Investment Partners’s AbbVie ABBV Stock Holding History

Davis Investment Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.22M	Sell	10,221 -504	-5%	-$112K	0.79%	20
2025 Q4	$2.46M	Sell	10,725 -928	-8%	-$211K	0.86%	16
2025 Q3	$2.84M	Sell	11,653 -308	-3%	-$62.7K	0.97%	16
2025 Q2	$2.27M	Buy	11,961 +70	+0.6%	+$13K	0.81%	19
2025 Q1	$2.13M	Buy	11,891 +2,610	+28%	+$507K	0.94%	16
2024 Q4	$1.63M	Hold	9,281	–	–	0.69%	26
2024 Q3	$1.83M	Sell	9,281 -119	-1%	-$22.2K	0.77%	20
2024 Q2	$1.6M	Hold	9,400	–	–	0.66%	27
2024 Q1	$1.59M	Hold	9,400	–	–	0.7%	26
2023 Q4	$1.52M	Buy	9,400 +263	+3%	+$38.3K	0.74%	23
2023 Q3	$1.35M	Hold	9,137	–	–	0.72%	23
2023 Q2	$1.3M	Hold	9,137	–	–	0.62%	26
2023 Q1	$1.46M	Hold	9,137	–	–	0.77%	21
2022 Q4	$1.4M	Buy	+9,137	New	+$1.4M	0.71%	24

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Davis Investment Partners's ABBV Position: Q1 2026 in Review

Davis Investment Partners reduced its AbbVie (ABBV) stake by 4.7% in Q1 2026, selling an estimated $112K and leaving 10,221 shares worth $2.22M. The position accounts for 0.79% of the portfolio, ranked #20.

Davis Investment Partners first reported a position in ABBV in Q4 2022 and has held it in 14 quarters since. The position peaked at $2.84M in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Davis Investment Partners held 10,221 shares of AbbVie worth $2.22M as of Q1 2026.
Davis Investment Partners sold 504 AbbVie shares in Q1 2026, an estimated $112K.
AbbVie made up 0.79% of Davis Investment Partners's portfolio in Q1 2026, its #20 holding.
Davis Investment Partners first reported a position in AbbVie in Q4 2022 and has held it in 14 quarters since.
Davis Investment Partners's AbbVie position peaked at $2.84M in Q3 2025.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Davis Investment Partners's 13F filing for Q1 2026, filed 20 Apr 2026.